Physician profile
Maureen E Czick
NPI 1386626653
$2,349.13
in general payments reported to CMS, 2019-2025
12 companies · $38.84 in 2025
The $38.84 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.54 · 2022: $184 · 2023: $1,517 · 2024: $521 · 2025: $38.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,076.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,076.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $531.03 | 2022-2024 | Xifaxan, Trulance |
| Abbvie INC. | $443.65 | 2023-2025 | Rinvoq, Skyrizi |
| Janssen Biotech, INC. | $320.93 | 2023-2024 | Stelara |
| Evoke Pharma, INC. | $254.71 | 2023 | Gimoti |
| Genzyme Corporation | $193.12 | 2022-2023 | |
| Intercept Pharmaceuticals, INC. | $169.94 | 2022-2023 | Ocaliva |
| Merck Sharp & Dohme LLC | $123.44 | 2019-2024 | Bridion |
| Regeneron Healthcare Solutions, INC. | $120.24 | 2022-2023 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $101.93 | 2023 | Gattex, Entyvio |
| Celgene Corporation | $45.66 | 2024 | Zeposia |
| Ironwood Pharmaceuticals, INC | $24.19 | 2023 | Linzess |
| E.R. Squibb & Sons, L.L.C. | $20.29 | 2023 | Zeposia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maureen Czick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.